A number of companies including 3M Co (NYSE:MMM), Actavis Inc (NYSE:ACT), Boston Scientific Corporation (NYSE:BSX), Bristol Myers Squibb Co. (NYSE:BMY), and Build-A-Bear Workshop, Inc (NYSE:BBW) are each scheduled to reports its quarterly financial results on Thursday, July 25, 2013.
3M Co (MMM)
Wall Street analysts projected that the earnings of 3M Co (NYSE:MMM) for the second quarter will increase to $1.71 per share from $1.66 per share in the same period ago. Its revenue is expected to be around $7.77 billion, 3 percent higher than its $7.53 billion revenue last year.
Gates Capital: Why (Free) Cash (Flow) Is King
Gates Capital Management's ECF value fund has earned strong returns for investors since its inception in June 1996. The ECF, or Excess Cash Flow Fund, had returned 12.9% annualized since inception to the end of September 2020. That was compared to 8.9% for the S&P 500 total return index and 7.4% for the HFRI Event-Driven Read More
For the full fiscal 2013, 3M Co (NYSE:MMM) is expected to post $6.71 earnings per share and $31.03 billion revenue. Last year, the company delivered $6.32 EPS and $29.90 billion revenue.
Actavis Inc (ACT)
Actavis Inc (NYSE:ACT) is projected by analysts to report second quarter earnings per share of $2.00, higher than its $1.42 EPS during the same period a year ago. The company’s revenue is estimated to increase by 46 percent from $1.36 billion to $1.98 billion.
Analysts anticipated that Actavis Inc (NYSE:ACT) will generate $8.32 earnings per share and $8.04 billion revenue for the full fiscal 2013. The company’s estimated revenue is 36 percent higher than its $5.91 billion revenue with $6.00 EPS in 2012.
Boston Scientific Corporation (BSX)
Boston Scientific Corporation (NYSE:BSX) financial performance for the second quarter is expected to decline. Analysts estimated that its earnings per share will be around $0.09, a decline of 18 percent from its $0.11 EPS in the same period a year ago. Its revenue is expected to drop by 2.8 percent from $1.83 billion to $1.78 billion.
For the full fiscal 2013, Boston Scientific Corporation (NYSE:BSX) is expected to generate $0.41 EPS and $7.05 billion revenue.
Bristol Myers Squibb Co
Bristol Myers Squibb Co. (NYSE:BMY) financial performance for the second quarter is expected by analysts to decline. The company recently announced its plan to cut 200 jobs in New Jersey next year as the company consolidates its marketing, information technology, and finance operations.
For the second quarter, the company’s earnings per share is estimated to drop from $0.48 to $0.44. Its revenue is projected to decline by 9 percent year-over-year from $4.44 billion to $4.05 billion. For the full fiscal 2013, Bristol Myers Squibb Co. (NYSE:BMY)’s is expected to generate $1.79 earnings per share and $16.34 billion revenue.
Build-A-Bear Workshop, Inc (BBW)
Meanwhile, analysts expected Build-A-Bear Workshop, Inc (NYSE:BBW) to report poor financial results for the second quarter. Analysts estimated that it will post $-0.35 losses per share and $77.20 million revenue. During the same period a year ago, the company posted -$0.46 losses per share and $80.41 million revenue. For the full fiscal 2013, the company is expected to post $0.35 EPS and $375.5 million revenue.